Is BRCA2 p.Asn1836del (c.5503AAT[1]) pathogenic?

BRCA2 p.Asn1836del (c.5503AAT[1]) is classified Uncertain significance in BRCA2 (ClinVar, Multiple submitters, 2 submitters; last evaluated 2024-03-30). Absent from gnomAD; Associated with hereditary breast ovarian cancer syndrome.

What condition is associated with BRCA2 p.Asn1836del (c.5503AAT[1])?

BRCA2 p.Asn1836del (c.5503AAT[1]) is associated with hereditary breast ovarian cancer syndrome (ClinVar).

How common is BRCA2 p.Asn1836del (c.5503AAT[1]) in the general population?

BRCA2 p.Asn1836del (c.5503AAT[1]) is absent from gnomAD (gnomAD).

How is Hereditary breast and/or ovarian cancer syndrome inherited?

Typically Autosomal dominant (Orphanet). A genetic counselor can assess individual risk for a family.

BRCA2 p.Asn1836del

c.5503AAT[1] · rs2072530967 · VCV954637

Uncertain significance Multiple submitters

Classification

Uncertain significance

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 2 submitters

gnomAD v4.1

Not reported

no gnomAD frequency available for this variant

Conditions

hereditary breast ovarian cancer syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · substitutions only
Constraint at this position
Conservation	phyloP 0.6	GERP -1.5, phastCons 0.001

Population frequency

dbSNP / gnomAD

No gnomAD frequency available for this variant. This is missing data, not an absence: the variant may or may not be present in gnomAD. Rarity (ACMG PM2) and BA1/BS1 cannot be assessed for it.

Variant & gene context

Gene: BRCA2
Protein: p.Asn1836del
Coding: c.5503AAT[1]
MANE Select: NM_000059
dbSNP: rs2072530967
Type: Microsatellite
Location: chr13:32339857 (GRCh38)
Gene constraint: LOEUF 0.803 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
Residue 1836: the 'interaction with rad51' region

Full BRCA2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary breast ovarian cancer syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Hereditary breast and/or ovarian cancer syndrome (Orphanet):

Inheritance: Autosomal dominant
Onset: Adult, Elderly

Similar variants

BRCA2 p.Asn1836His Conflicting classifications of pathogenicity ★ ⚠ same residue
BRCA2 p.Asn1836Lys Conflicting classifications of pathogenicity ★ same residue
BRCA2 p.Asn1836Ser Conflicting classifications of pathogenicity ★ ⚠ same residue
BRCA2 p.Asn1836Thr Conflicting classifications of pathogenicity ★ ⚠ same residue
BRCA2 p.Asn1836= Likely benign ★ same residue
BRCA2 p.Ala1439fs Pathogenic ★★★ same condition
BRCA2 p.Ala1725Ter Pathogenic ★★★ same condition
BRCA2 p.Arg155_Asp156insTer Pathogenic ★★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brca2-p-asn1836del (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown